[HTML][HTML] Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation.

E Thurgar, S Barton, C Karner… - Health Technology …, 2016 - ncbi.nlm.nih.gov
BACKGROUND Typically occurring on the external genitalia, anogenital warts (AGWs) are
benign epithelial skin lesions caused by human papillomavirus infection. AGWs are usually …

[引用][C] Management of anogenital warts (condylomata acuminata)

G Von Krogh - European Journal of Dermatology, 2001 - jle.com
JLE - European Journal of Dermatology - Management of anogenital warts (condylomata
acuminata) JLE Home Bookstore Search for books Collections New books and E-books …

Intralesional immunotherapy with killed Mycobacterium w vaccine for the treatment of ano‐genital warts: an open label pilot study

S Gupta, AK Malhotra, KK Verma… - Journal of the …, 2008 - Wiley Online Library
Background Intralesional immunotherapy with skin test antigens and vaccines has been
found to be effective in the management of genital and extragenital warts. Objective To …

Systematic review of the incidence and prevalence of genital warts

H Patel, M Wagner, P Singhal, S Kothari - BMC infectious diseases, 2013 - Springer
Abstract Background Anogenital warts (AGWs) are a common, highly infectious disease
caused by the human papillomavirus (HPV), whose high recurrence rates contribute to direct …

Genital warts and other HPV infections: Established and novel therapies

R Fathi, MM Tsoukas - Clinics in dermatology, 2014 - Elsevier
Wart therapies involve methods of targeted lesion destruction, as well as selective
immunologic modification. While there are several therapeutic options, no treatment has …

[HTML][HTML] Genital warts

N Scheinfeld - Dermatology online journal, 2006 - escholarship.org
Genital human papillomavirus (HPV) infection is the most common sexually transmitted
disease. Each year 1 million new cases of genital warts are diagnosed, two thirds of which …

The impact of anogenital warts on health-related quality of life: a 6-month prospective study

M Drolet, M Brisson, E Maunsell… - Sexually transmitted …, 2011 - journals.lww.com
Background: The burden of anogenital warts will be a determining factor when making
decisions about the type of human papillomavirus (HPV) vaccine to be used (bivalent or …

Human papillomavirus and genital warts: a review of the evidence for the 2015 centers for disease control and prevention sexually transmitted diseases treatment …

IU Park, C Introcaso, EF Dunne - Clinical Infectious Diseases, 2015 - academic.oup.com
To provide updates for the 2015 Centers for Disease Control and Prevention sexually
transmitted diseases treatment guidelines on human papillomavirus (HPV) and anogenital …

Management of external genital warts

JB Karnes, RP Usatine - American family physician, 2014 - aafp.org
Genital warts affect 1% of the sexually active US population and are commonly seen in
primary care. Human papillomavirus types 6 and 11 are responsible for most genital warts …

Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts—results of an open-label, multicentre Phase IIIB trial

SM Garland, JW Sellors, A Wikstrom… - … journal of STD & …, 2001 - journals.sagepub.com
Our objective was to determine the efficacy and safety of imiquimod 5% cream in the
treatment of external genital/perianal warts in an open-label Phase IIIB trial. Patients applied …